New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2014
16:31 EDTGSK, STRZA, SU, DVA, LBTYA, DISH, LMCA, USB, XOM, BRK.B, MCO, COP, USG, WFC, BRK.ABerkshire Hathaway gives quarterly update on stakes
NEW STAKES: Liberty Global (LBTYA). INCREASED STAKES: Wells Fargo (WFC), Exxon Mobil (XOM), Davita (DVA), USG (USG) and US Bancorp (USB). DECREASED STAKES: Suncor (SU), ConocoPhillips (COP), Liberty Media (LMCA), Starz (STRZA) and Moody's (MCO). LIQUIDATED STAKES: Dish Network (DISH) and GlaxoSmithKline (GSK).
News For B;LBTYA;WFC;XOM;DVA;USG;USB;SU;COP;LMCA;STRZA;MCO;DISH;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 25, 2015
16:42 EDTDISHFCC Chairman outlines changes to future spectrum auctions
Subscribe for More Information
14:01 EDTGSKGlaxoSmithKline initiated with a Buy at HSBC
Price target GBP 17.
13:08 EDTXOMPenn Virginia higher after blog speculates on another deal
Subscribe for More Information
12:07 EDTXOMBP said to make $8/share bid for Penn Virginia, Proactive Investors blog says
BP (BP) has made a $8 per share takeover bid for Penn Virginia (PVA), but the latter rejected the bid and is "holding out" for at least $10 per share, UK investor blog Proactive Investors claimed, citing people familiar with the matter. ExxonMobil (XOM) and Chevron (CVX) may also be interested in buying Penn Virginia, according to Proactive, which identifies itself as a "leading multi-media news organisation, investor portal and events management business." Penn Virginia shares are up 7% in midday trading following the report from the blog, which was previously credited for a report on alleged takeover advances made toward drugmaker Receptos (RCPT). Reference Link
07:13 EDTUSB, WFCFed director says full transparency in stress testing can be 'enormous weakness'
Subscribe for More Information
June 24, 2015
18:16 EDTXOMGoogle, GE, Airbus lead in sheer number of meetings with EU officials
Subscribe for More Information
13:37 EDTGSKGSK says CDC committee votedfor meningococcal group B vaccines
GlaxoSmithKline (GSK) announced that the U.S. Centers for Disease Control Advisory Committee on Immunization Practices voted for a Category B recommendation for meningococcal group B vaccination, including Bexsero, in individuals aged 16 to 23. Bexsero was approved by the FDA in January for use in individuals aged 10 through 25 years and acquired by GSK in March following the closure of the three-part transaction with Novartis (NVS).
11:12 EDTCOPConocoPhillips management to meet with Jefferies
Subscribe for More Information
08:56 EDTUSBU.S. Bancorp profited from buying bonds for below market prices, WSJ says
Subscribe for More Information
08:40 EDTXOMExxon closes oil production off Santa Barbara after pipe burst, L.A. Times says
Subscribe for More Information
07:38 EDTSUSuncor management to meet with JPMorgan
Subscribe for More Information
07:19 EDTCOP, XOMU.K. panel to decide on first fracking in area since 2011, WSJ reports
Subscribe for More Information
06:55 EDTLBTYALiberty Global in talks to acquire TV3, Financial Times reports
Subscribe for More Information
06:32 EDTDVADaVita discloses it received subpoena from Inspector General
In a regulatory filing, DaVita disclosed that the company recently received a subpoena from the Office of Inspector General, U.S. Department of Health and Human Services. This civil subpoena covers the period from January 1, 2008 through the present and seeks production of a wide range of documents relating to the company’s and its subsidiaries’ provision of services to Medicare Advantage plans and Medicare Advantage organizations and related patient diagnosis coding and risk adjustment submissions and payments. DaVita believes that the request is part of a broader industry investigation into Medicare Advantage patient diagnosis coding and risk adjustment practices and potential overpayments by the government. In the event that the company were to incur liability related to this matter, the company would pursue an indemnification claim against the sellers secured by the escrow. We can make no assurances that the indemnification and escrow would cover the full amount of our potential losses related to this matter. The company is cooperating with the government and will gather and produce the requested information.
06:30 EDTDVADaVita discloses Robert Margolis not re-nominated as co-chairman of company
Subscribe for More Information
06:12 EDTLBTYALiberty Global to focus on growing in existing European markets, Reuters says
Liberty Global (LBTYA) CEO Michael Fries told Germany's Handelsblatt that the company plans to focus on growing in its existing markets in Europe, Reuters reports, and that markets where the company is not active "do not interest us." Though Fries did not comment on talks with Vodafone (VOD), he said Liberty does not need to buy other companies to grow in the markets where it already operates. Reference Link
June 23, 2015
13:02 EDTWFCSumitomo, others show interest in GE railway-leasing business, WSJ says
Japan's Sumitomo Mitsui Financial Group is interested in buying General Electric's (GE) railway-leasing business, says the Wall Street Journal, citing sources. Wells Fargo (WFC) and other U.S. financial institutions have also shown interest in GE Capital Rail Services, which may be worth around $4B, added the Wall Street Journal, citing people familiar with the matter. Reference Link
07:25 EDTGSKPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
15:04 EDTDISHT-Mobile could abandon DISH for Comcast, Forbes contributor says
Subscribe for More Information
07:01 EDTGSKPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use